Cells growing in CnT-Prime MSC medium also demonstrate extended longevity, and remain strongly multipotent for at least 4 passages.
It can easily be upgraded for clinical applications by replacing the FCS with human serum. Contact us at firstname.lastname@example.org for further details and pricing.
The cell population is CD45-/CD31-/CD73+/CD90+/CD105+/CD34+/-, and importantly at least 10% of the cell population remains CD34-positive at passage 4.
Figure: CD34 expression, CnT-PR-MSC medium, passage 4.
Cells may at any time be switched to the xeno-free #CnT-PR-MSC-XF medium, or induced to differentiate following addition of the necessary differentiation supplements. Please visit the MSC homepage for more information about other Prime MSC products.
For recommended isolation, expansion, differentiation and CFE protocols, please visit the Protocols Section of this website.
Please view the Culture Notes document for specific recommendations regarding the use of the CnT-Prime MSC-CD medium.
The CnT-PR-MSC medium is currently in the beta testing phase. Please contact email@example.com to request your test sample.
A flyer summarising the CnT-Prime MSC expansion media is available here.